Sharon Pitteri
Overview
Explore the profile of Sharon Pitteri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
A subcellular map of translational machinery composition and regulation at the single-molecule level
Zhang Z, Xu A, Bai Y, Chen Y, Cates K, Kerr C, et al.
Science
. 2025 Mar;
387(6738):eadn2623.
PMID: 40048539
Millions of ribosomes are packed within mammalian cells, yet we lack tools to visualize them in toto and characterize their subcellular composition. In this study, we present ribosome expansion microscopy...
2.
Reffai A, Hori M, Adusumilli R, Bermudez A, Bouzoubaa A, Pitteri S, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409902
Background: Nasopharyngeal carcinoma (NPC) is a distinct cancer of the head and neck that is highly prevalent in Southeast Asia and North Africa. Though an extensive analysis of environmental and...
3.
Dheeraj A, Marques F, Tailor D, Bermudez A, Resendez A, Pandrala M, et al.
Cell Rep Med
. 2024 May;
5(5):101552.
PMID: 38729158
Y-box binding protein-1 (YB-1) is a proto-oncogenic protein associated with protein translation regulation. It plays a crucial role in the development and progression of triple-negative breast cancer (TNBC). In this...
4.
Chamoli M, Rane A, Foulger A, Chinta S, Shahmirzadi A, Kumsta C, et al.
Nat Aging
. 2023 Nov;
3(12):1529-1543.
PMID: 37957360
Autophagy-lysosomal function is crucial for maintaining healthy lifespan and preventing age-related diseases. The transcription factor TFEB plays a key role in regulating this pathway. Decreased TFEB expression is associated with...
5.
Hodgson K, Orozco-Moreno M, Scott E, Garnham R, Livermore K, Thomas H, et al.
Sci Rep
. 2023 Oct;
13(1):17031.
PMID: 37813880
Prostate cancer is the most common cancer in men and a major cause of cancer related deaths worldwide. Nearly all affected men develop resistance to current therapies and there is...
6.
Scott E, Goode E, Garnham R, Hodgson K, Orozco-Moreno M, Turner H, et al.
J Pathol
. 2023 Aug;
261(1):71-84.
PMID: 37550801
Aberrant glycosylation is a universal feature of cancer cells, and cancer-associated glycans have been detected in virtually every cancer type. A common change in tumour cell glycosylation is an increase...
7.
Scott E, Hodgson K, Calle B, Turner H, Cheung K, Bermudez A, et al.
Oncogene
. 2023 Feb;
42(12):926-937.
PMID: 36725887
Prostate cancer is the most common cancer in men and it is estimated that over 350,000 men worldwide die of prostate cancer every year. There remains an unmet clinical need...
8.
Yoshikawa A, Rangel A, Feagin T, Chun E, Wan L, Li A, et al.
Nat Commun
. 2022 Jun;
13(1):3452.
PMID: 35705534
No abstract available.
9.
Bose R, Kumar U, Garcia-Marques F, Zeng Y, Habte F, McCarthy J, et al.
Adv Healthc Mater
. 2021 Dec;
11(5):e2101387.
PMID: 34879180
Polymeric nanocarriers (PNCs) can be used to deliver therapeutic microRNAs (miRNAs) to solid cancers. However, the ability of these nanocarriers to specifically target tumors remains a challenge. Alternatively, extracellular vesicles...
10.
Yoshikawa A, Rangel A, Feagin T, Chun E, Wan L, Li A, et al.
Nat Commun
. 2021 Dec;
12(1):7106.
PMID: 34876561
Glycosylation is one of the most abundant forms of post-translational modification, and can have a profound impact on a wide range of biological processes and diseases. Unfortunately, efforts to characterize...